Zhejiang Dayang Biotech Group Co (003017) - Total Liabilities

Latest as of March 2026: CN¥706.73 Million CNY ≈ $103.42 Million USD

Based on the latest financial reports, Zhejiang Dayang Biotech Group Co (003017) has total liabilities worth CN¥706.73 Million CNY (≈ $103.42 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Zhejiang Dayang Biotech Group Co - Total Liabilities Trend (2013–2025)

This chart illustrates how Zhejiang Dayang Biotech Group Co's total liabilities have evolved over time, based on quarterly financial data. See working capital to net assets of Zhejiang Dayang Biotech Group Co to evaluate short-term liquidity relative to the company's equity base.

Zhejiang Dayang Biotech Group Co Competitors by Total Liabilities

The table below lists competitors of Zhejiang Dayang Biotech Group Co ranked by their total liabilities.

Company	Country	Total Liabilities
Zoneco Group Co Ltd SHE:002069	China	CN¥2.10 Billion
Jiangsu Wanlin Modern Logistic SHG:603117	China	CN¥317.29 Million
Simulations Plus Inc NASDAQ:SLP	USA	$12.71 Million
Egis Technology TWO:6462	Taiwan	NT$5.77 Billion
Hainan Yedao Group Co Ltd SHG:600238	China	CN¥742.70 Million
ITAFOS INC. ON F:82E	Germany	€378.91 Million
Suzhou Fushilai Pharmaceutical Co. Ltd. SHE:301258	China	CN¥211.52 Million
Ve Wong Corp TW:1203	Taiwan	NT$3.14 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down Zhejiang Dayang Biotech Group Co's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 003017 company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.23	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.61	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.38	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Zhejiang Dayang Biotech Group Co's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Zhejiang Dayang Biotech Group Co (2013–2025)

The table below shows the annual total liabilities of Zhejiang Dayang Biotech Group Co from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥681.72 Million ≈ $99.76 Million	+13.54%
2024-12-31	CN¥600.40 Million ≈ $87.86 Million	+11.50%
2023-12-31	CN¥538.47 Million ≈ $78.79 Million	+2.97%
2022-12-31	CN¥522.92 Million ≈ $76.52 Million	+36.31%
2021-12-31	CN¥383.64 Million ≈ $56.14 Million	+41.74%
2020-12-31	CN¥270.67 Million ≈ $39.61 Million	+83.49%
2019-12-31	CN¥147.51 Million ≈ $21.59 Million	-8.37%
2018-12-31	CN¥160.99 Million ≈ $23.56 Million	-8.20%
2017-12-31	CN¥175.37 Million ≈ $25.66 Million	-26.12%
2016-12-31	CN¥237.37 Million ≈ $34.73 Million	-4.72%
2015-12-31	CN¥249.12 Million ≈ $36.45 Million	-6.50%
2014-12-31	CN¥266.43 Million ≈ $38.99 Million	+4.92%
2013-12-31	CN¥253.93 Million ≈ $37.16 Million	--

About Zhejiang Dayang Biotech Group Co

SHE:003017 China Chemicals

Market Cap

$323.40 Million

CN¥2.21 Billion CNY

Market Cap Rank

#14555 Global

#4348 in China

Share Price

CN¥26.31

Change (1 day)

-1.97%

52-Week Range

CN¥25.08 - CN¥36.52

All Time High

CN¥39.37